# 📄 MEDORA — Master Phase 7 Specification

## Master Phase 7: Digital Consultation & Prescription

**Status**: `VERIFIED`  
**Sub-Phases**: Phase 7.1, Phase 7.2, Phase 7.3, Phase 7.4  

---

## 1. Executive Summary

Master Phase 7 establishes MEDORA's complete **Digital Consultation & Clinical Workflow Architecture**, spanning queue-to-encounter handoff, SOAP documentation, digital prescriptions, lab orders, specialty referrals, follow-up recommendations, and cross-module hardening.

```
┌────────────────────────────────────────────────────────────────────────────────────────┐
│                              MASTER PHASE 7 SUB-PHASES                                 │
├──────────────────────────┬──────────────────────────┬──────────────────────────────────┤
│ PHASE 7.1                │ PHASE 7.2                │ PHASE 7.3                        │
│ Clinical Encounter &     │ Digital Prescription &   │ Lab Orders, Referrals &          │
│ SOAP Documentation       │ Medication Workflow      │ Follow-Up Recommendations        │
├──────────────────────────┼──────────────────────────┼──────────────────────────────────┤
│ • Queue-to-Encounter     │ • Structured Items       │ • Multi-Test Lab Orders          │
│ • Idempotent Starts      │ • Digital Signature Hash │ • Specialty Referrals            │
│ • SOAP & Vitals          │ • Versioning / Correction│ • Follow-Up & Phase 6 Linkage    │
│ • Draft Autosave         │ • Open Pharmacy Freedom  │ • Phase 8 Handoff Payload        │
├──────────────────────────┴──────────────────────────┴──────────────────────────────────┤
│ PHASE 7.4                                                                              │
│ Clinical Workflow Integration, Data Integrity & Final Hardening                        │
│ • Clinical Graph Integrity Engine • Double-Click Idempotency Guards                     │
│ • Anti-IDOR Security • Audit Trail Completeness • 100% Platform Regression Pass        │
└────────────────────────────────────────────────────────────────────────────────────────┘
```

---

## 2. Sub-Phase Architecture Overview

| Sub-Phase | Focus | Test Suite | Pass Rate | Status |
| :--- | :--- | :--- | :---: | :---: |
| **Phase 7.1** | Encounter Foundation, SOAP & Security | `scripts/test-phase-7-1-clinical-encounter.ts` | 39 / 39 (100%) | `VERIFIED` |
| **Phase 7.2** | Prescriptions, Verification & Pharmacy Handoff | `scripts/test-phase-7-2-prescription-workflow.ts` | 49 / 49 (100%) | `VERIFIED` |
| **Phase 7.3** | Lab Orders, Referrals & Follow-Up | `scripts/test-phase-7-3-lab-referral-followup.ts` | 40 / 40 (100%) | `VERIFIED` |
| **Phase 7.4** | Integrity, Hardening & Master Verification | `scripts/test-phase-7-4-hardening-integration.ts` | 12 / 12 (100%) | `VERIFIED` |
| **Master Suite** | Comprehensive Master Phase 7 | `scripts/test-phase-7-master-comprehensive.ts` | **140 / 140 (100%)** | **`VERIFIED`** |

---

## 3. Core Clinical Invariants

1. **Non-Autonomous Decision Boundary**: System NEVER auto-prescribes or auto-orders tests.
2. **Phase Boundary Separation**: Prescriptions $\neq$ Pharmacy Fulfillment; Lab Orders $\neq$ Lab Results.
3. **Open Patient Choice**: Patients can fulfill prescriptions and lab orders at any facility of choice.
4. **Complete Traceability**: Every clinical record links to an authoritative encounter, clinician, facility, and audit trail.
